MRT Inc. (TYO:6034)
750.00
+54.00 (7.76%)
May 28, 2025, 3:30 PM JST
MRT Inc. Revenue
MRT Inc. had revenue of 996.00M JPY in the quarter ending March 31, 2025, with 6.30% growth. This brings the company's revenue in the last twelve months to 4.22B, down -7.75% year-over-year. In the year 2024, MRT Inc. had annual revenue of 4.17B, down -22.97%.
Revenue (ttm)
4.22B
Revenue Growth
-7.75%
P/S Ratio
0.99
Revenue / Employee
13.89M
Employees
288
Market Cap
4.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.17B | -1.24B | -22.97% |
Dec 31, 2023 | 5.41B | -3.33B | -38.12% |
Dec 31, 2022 | 8.74B | 4.27B | 95.52% |
Dec 31, 2021 | 4.47B | 1.91B | 74.43% |
Dec 31, 2020 | 2.56B | 84.00M | 3.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |